Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 84
Filter
1.
Pharmacoepidemiol Drug Saf ; 2022 Nov 05.
Article in English | MEDLINE | ID: covidwho-2242131

ABSTRACT

BACKGROUND: Patients use social media forums to discuss their medical history and healthcare experiences, providing early insight into real-world patient experiences. We analyzed COVID-19 patient experiences from Reddit social media posts. METHODS: We extracted Reddit Application Programming Interface data for the subreddit/COVID-19 positive from March to August 2020 and selected users tagged as "Tested Positive" or "Tested Positive- Me" flair and who posted at least thirty times in any calendar month, excluding users who explicitly stated location outside of the U.S. For tested-positive patients (users), we created and reviewed individual case profiles summarizing their COVID-19 symptoms, testing, and medications or treatments. Data were imported to Nvivo qualitative analysis software and qualitative coding was conducted. FINDING: There were 31 759 posts and comments from 720 users in March to May 2020 (Q1) and 40 446 posts and comments from 1649 users from June to August 2020 (Q2). Final count of "Tested Positive" was 1296 users (280 in Q1 and 1016 in Q2). Across both quarters, frequently reported symptoms included sore throat, headaches, fevers, or chills. Loss of sense of smell or taste were reported by users in early March, prior to the inclusion of this symptom to the CDC list in April and GI-related symptoms and fatigue were reported in the March to May data, before they were added as a COVID-19 associated symptom in July 2020. Users also reported in-depth descriptions of their symptoms, motivations for testing, and long-term impacts such as post-viral fatigue. INTERPRETATION: Social media data can potentially serve as an early surveillance data source in a pandemic and offer preliminary insights into patient disease experiences.

2.
Open Forum Infectious Diseases ; 9(Supplement 2):S540, 2022.
Article in English | EMBASE | ID: covidwho-2189827
3.
Journal of the Academy of Consultation-Liaison Psychiatry ; 63(Supplement 2):S121-S122, 2022.
Article in English | EMBASE | ID: covidwho-2179913
4.
Current Bladder Dysfunction Reports ; 17(4):204-209, 2022.
Article in English | EMBASE | ID: covidwho-2174982
5.
Quality of Life Research ; 31(Supplement 2):S113, 2022.
Article in English | EMBASE | ID: covidwho-2174738
6.
Patient Experience Journal ; 9(2):62-70, 2022.
Article in English | Scopus | ID: covidwho-2156204
7.
Patient Experience Journal ; 9(3):191-208, 2022.
Article in English | Scopus | ID: covidwho-2156203
8.
Patient Experience Journal ; 9(1):62-71, 2022.
Article in English | Scopus | ID: covidwho-2156202
9.
Patient Experience Journal ; 9(1):95-102, 2022.
Article in English | Scopus | ID: covidwho-2156198
10.
Patient Experience Journal ; 9(1):205-211, 2022.
Article in English | Scopus | ID: covidwho-2156196
11.
Patient Education and Counseling ; 105(11):3331-3333, 2022.
Article in English | APA PsycInfo | ID: covidwho-2132048
13.
Pharmacoepidemiol Drug Saf ; 2022 Nov 05.
Article in English | MEDLINE | ID: covidwho-2103683

ABSTRACT

BACKGROUND: Patients use social media forums to discuss their medical history and healthcare experiences, providing early insight into real-world patient experiences. We analyzed COVID-19 patient experiences from Reddit social media posts. METHODS: We extracted Reddit Application Programming Interface data for the subreddit/COVID-19 positive from March to August 2020 and selected users tagged as "Tested Positive" or "Tested Positive- Me" flair and who posted at least thirty times in any calendar month, excluding users who explicitly stated location outside of the U.S. For tested-positive patients (users), we created and reviewed individual case profiles summarizing their COVID-19 symptoms, testing, and medications or treatments. Data were imported to Nvivo qualitative analysis software and qualitative coding was conducted. FINDING: There were 31 759 posts and comments from 720 users in March to May 2020 (Q1) and 40 446 posts and comments from 1649 users from June to August 2020 (Q2). Final count of "Tested Positive" was 1296 users (280 in Q1 and 1016 in Q2). Across both quarters, frequently reported symptoms included sore throat, headaches, fevers, or chills. Loss of sense of smell or taste were reported by users in early March, prior to the inclusion of this symptom to the CDC list in April and GI-related symptoms and fatigue were reported in the March to May data, before they were added as a COVID-19 associated symptom in July 2020. Users also reported in-depth descriptions of their symptoms, motivations for testing, and long-term impacts such as post-viral fatigue. INTERPRETATION: Social media data can potentially serve as an early surveillance data source in a pandemic and offer preliminary insights into patient disease experiences.

14.
Pharmaceutical Journal ; 309(7964), 2022.
Article in English | EMBASE | ID: covidwho-2065049
15.
Obstetric Medicine ; 15(1 Supplement):15, 2022.
Article in English | EMBASE | ID: covidwho-2064391
16.
10th IEEE International Conference on Healthcare Informatics, ICHI 2022 ; : 384-392, 2022.
Article in English | Scopus | ID: covidwho-2063252
17.
Epilepsy Behav ; 130: 108673, 2022 05.
Article in English | MEDLINE | ID: covidwho-2061987

ABSTRACT

BACKGROUND: Health research agendas are often set by researchers or by industry and may not reflect the needs and priorities of end users. This priority-setting partnership (PSP) for epilepsy was undertaken to identify the most pressing unanswered questions about epilepsy and seizures from the perspective of people with epilepsy (PWE) and their care providers. METHODS: Using the methodology developed by the James Lind Alliance (JLA), evidence uncertainties were gathered via online surveys from stakeholders across Canada. Submissions were formed into summary questions and checked against existing evidence to determine if they were true uncertainties. Verified uncertainties were then ranked by patients, caregivers, and healthcare providers and a final workshop was held to reach a consensus on the top 10 priorities. RESULTS: The final top 10 list reflects the priority areas of focus for research as identified by the Canadian epilepsy community, including genetic markers for diagnosis and treatment, concerns about living with the long-term effects of epilepsy, and addressing knowledge gaps in etiology and treatment approaches. CONCLUSION: This project represents the first systematic evidence of patient- and clinician-centered research priorities for epilepsy. The results of this priority-setting exercise provide an opportunity for researchers and funding agencies to align their agendas with the values and needs of the epilepsy community in order to improve clinical outcomes and quality of life (QOL) for PWE.


Subject(s)
Epilepsy , Quality of Life , Canada , Caregivers , Epilepsy/diagnosis , Epilepsy/therapy , Humans , Surveys and Questionnaires
18.
Tropical Medicine and Health ; 50(1), 2022.
Article in English | EMBASE | ID: covidwho-2043147
19.
Anaesthesia ; 77:12, 2022.
Article in English | EMBASE | ID: covidwho-2032346
20.
Journal of the American Academy of Dermatology ; 87(3):AB210, 2022.
Article in English | EMBASE | ID: covidwho-2031399
SELECTION OF CITATIONS
SEARCH DETAIL